NOVA BIO-PHARMA HOLDINGS LIMITED
NOVA BIO-PHARMA HOLDINGS LIMITED is a Private limited company (Ltd.) registered in United Kingdom under 06600173, and its current status with Companies House is active. The company was incorporated on 22 May 2008 and lists its registered address as WIGSTON, United Kingdom. 5 shareholders are on record for NOVA BIO-PHARMA HOLDINGS LIMITED, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Companies House and was last updated on 9 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for NOVA BIO-PHARMA HOLDINGS LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006.
The largest of these is PETER JOHN PITT WHITE, holding 30% — the largest recorded stake — followed by REGINA TERESA WHITE at 25%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 13 shareholders in total, though only the top 5 by holding are shown in this view.
Every shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| PETER JOHN PITT WHITE | 30% | Companies House | |
| REGINA TERESA WHITE | 25% | Companies House | |
| JANET MARY GOODALL | 6% | Companies House | |
| PATRICIA ANNE TAYLOR | 4.5% | Companies House | |
| JAMES TAYLOR | 4.5% | Companies House |
Officers
5
Four of the 5 officer records shown for NOVA BIO-PHARMA HOLDINGS LIMITED are current appointments, filed with Companies House. Peter White (appointed 2008-05-22), NOVA NOMINEES LIMITED (appointed 2014-11-17) and James White (appointed 2020-10-08) all serve as Director; Karen Leishman (appointed 2024-01-01) serves as Company Secretary. The remaining 1 record shown (Clement Staniforth) is a former appointment that has since been resigned.
The register reports 7 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at NOVA BIO-PHARMA HOLDINGS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
NOVA BIO-PHARMA HOLDINGS LIMITED has no recorded parent company — it sits at the top of its own group structure, with 8 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 8 subsidiaries span United Kingdom, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 8 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
NOVA BIO-PHARMA HOLDINGS LIMITED
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns NOVA BIO-PHARMA HOLDINGS LIMITED?
Five shareholders are currently on record for NOVA BIO-PHARMA HOLDINGS LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is PETER JOHN PITT WHITE, holding 30% — the largest recorded stake — followed by REGINA TERESA WHITE at 25%; the remaining 3 shareholders shown hold smaller stakes. Every shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.
Who is NOVA BIO-PHARMA HOLDINGS LIMITED's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for NOVA BIO-PHARMA HOLDINGS LIMITED is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does NOVA BIO-PHARMA HOLDINGS LIMITED have on record?
5 shareholders are shown on record for NOVA BIO-PHARMA HOLDINGS LIMITED. The register reports 13 in total; only the top 5 by holding are shown here.
What is NOVA BIO-PHARMA HOLDINGS LIMITED's company registration number?
NOVA BIO-PHARMA HOLDINGS LIMITED's registration number is 06600173, filed with Companies House in United Kingdom. Its current status on the register is active.
Is NOVA BIO-PHARMA HOLDINGS LIMITED still an active company?
NOVA BIO-PHARMA HOLDINGS LIMITED's status on Companies House is listed as active.
When was NOVA BIO-PHARMA HOLDINGS LIMITED incorporated?
NOVA BIO-PHARMA HOLDINGS LIMITED was incorporated on 22 May 2008, according to Companies House.
What is NOVA BIO-PHARMA HOLDINGS LIMITED's registered address?
The registered address on file for NOVA BIO-PHARMA HOLDINGS LIMITED is WIGSTON, United Kingdom.
What legal structure is NOVA BIO-PHARMA HOLDINGS LIMITED registered as?
NOVA BIO-PHARMA HOLDINGS LIMITED is registered as a Private limited company (Ltd.) in United Kingdom.
Who are the officers/directors of NOVA BIO-PHARMA HOLDINGS LIMITED?
Four of the 5 officer records shown for NOVA BIO-PHARMA HOLDINGS LIMITED are current appointments, filed with Companies House. Peter White (appointed 2008-05-22), NOVA NOMINEES LIMITED (appointed 2014-11-17) and James White (appointed 2020-10-08) all serve as Director; Karen Leishman (appointed 2024-01-01) serves as Company Secretary. The remaining 1 record shown (Clement Staniforth) is a former appointment that has since been resigned. Management authority at NOVA BIO-PHARMA HOLDINGS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does NOVA BIO-PHARMA HOLDINGS LIMITED have a parent company or subsidiaries?
NOVA BIO-PHARMA HOLDINGS LIMITED has no recorded parent company — it sits at the top of its own group structure, with 8 subsidiaries recorded beneath it across 2 jurisdictions. Those 8 subsidiaries span United Kingdom, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 8 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to NOVA BIO-PHARMA HOLDINGS LIMITED's ownership over time?
This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to NOVA BIO-PHARMA HOLDINGS LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access NOVA BIO-PHARMA HOLDINGS LIMITED's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like NOVA BIO-PHARMA HOLDINGS LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies House and was last synced on 9 October 2026.